GLP-1 secretion is reduced in type 2 diabetes patients after an oral glucose load and during a meal test, whereas stimulation of insulin secretion by GLP-1 infusion is relatively well preserved in diabetic patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.